RG-6351
N/A
Report date: 2023/01/03 10:19:58
Base Information
Drug NameRG-6351
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A